Skip to main content

Szabo Lab

Home

Primary menu

Research
Publications
Funding
Team
News
Contact

- Search

Home
Publications
Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.

Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.

Zhuang Y, Szabo G. Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.. Hepatology (Baltimore, Md.). 2024;80(1):E2-E3. PMID: 38442007

Publisher's Version

Last updated on 09/19/2024
PubMed

Recent Publications

Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Natural history and development of a novel composite endpoint in patients with alcohol-associated Hepatitis: Data from a prospective multicenter study.
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.
Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer's disease associated with inflammasome activation and ASC speck propagation.
The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.

Szabo Lab

Powered byOpenScholar^®Admin Login